Document is current
Any future updates will be listed below
-
Authors
Kosaka, Kentaro https://orcid.org/0009-0002-6858-9870
Takayama, Naoya
Paul, Sudip Kumar
Kanashiro, Maria Alejandra
Oshima, Motohiko
Fukuyo, Masaki
Rahmutulla, Bahityar
Tajiri, Ikuko
Mukai, Michiaki
Kubota, Yoshitaka
Akita, Shinsuke
Furuyama, Nobutaka
Kaneda, Atsushi
Iwama, Atsushi
Eto, Koji
Mitsukawa, Nobuyuki
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP21K16921, JP23K09095, 21H05047S)
Terumo Life Science Foundation (19-II401)
Jiyugaoka Clinic Doctor’s Cosmetics (Jiyugaoka Clinic Doctor’s Cosmetics)
Shin-kuki General Hospital (Shin-kuki General Hospital)
Shin-yurigaoka General Hospital (Shin-yurigaoka General Hospital)
Incubation Program of Kyoto University (Incubation Program of Kyoto University)
SBC Medical Promotion Foundation (SBC Medical Promotion Foundation)
- License Information
-
More Information
Article History
Received: 15 March 2024
Accepted: 30 September 2024
First Online: 14 October 2024
Declarations
:
: This study was conducted according to the principles outlined in the Declaration of Helsinki and after receiving approval by the Ethics Committee of Chiba University (approval number: 1045, approval date: 20 February 2020, name of project: Clinical research for the development of artificial platelets with expanded function). All subjects provided informed written consent for the collection of samples and subsequent analysis. All animal experiments were approved by the Chiba University Institutional Animal Care and Use Committee (approval number: 5-158, approval date: 9 March 2023, name of project: Research for the development of artificial platelets with disease-specific therapeutic factors.).
: Not applicable.
: K.K., N.T., M.M. and K.E. hold stock of Kineplat Co.Ltd. that has a related patent of this research.
